<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02626195</url>
  </required_header>
  <id_info>
    <org_study_id>NCCCTS-13-676</org_study_id>
    <nct_id>NCT02626195</nct_id>
  </id_info>
  <brief_title>Preoperative Nutritional Support in Malnutritional Cancer Patients</brief_title>
  <official_title>Prospective Study of Preoperative Nutritional Support in Malnutritional Pancreatobiliary Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malnutrition patients are known to have more postoperative complications and mortality. And&#xD;
      most of hepatobiliary-pancreatic cancer surgeries accompany high postoperative morbidity and&#xD;
      mortality rate. Therefore for the malnourished patients anticipating major surgery,&#xD;
      preoperative nutritional support is recommended according to the ASPEN (American society of&#xD;
      parenteral and enteral nutrition) and ESPEN (European society of parenteral and enteral&#xD;
      nutrition) guideline. However there is no prospective trial to prove the clinical impact of&#xD;
      preoperative nutritional support for malnourished patients.&#xD;
&#xD;
      The purpose of this study is to evaluate the clinical impact of preoperative nutritional&#xD;
      support for malnourished cancer patients anticipating HBP surgery. Primary objective is to&#xD;
      compare the complication rate and secondary object is to compare the quality of life,&#xD;
      hospital stay and cost.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is single arm study with historical comparison. The historical control group did not&#xD;
      receiving nutritional support. In previous results show that about 25% complication rates.&#xD;
      Complication rates are expected in the group receiving nutritional support is less than 10 %&#xD;
      ( previous studies (NCCNCS-11-460)).&#xD;
&#xD;
      For support group, preoperative nutritional support is given for 5 or more days&#xD;
      preoperatively by nutritional support program. Nutritional support program is briefly&#xD;
      described below.&#xD;
&#xD;
      Interval: 5-10 days Contents: admission is required&#xD;
&#xD;
        -  Calories: 30-35Kg, via enteral or parenteral&#xD;
&#xD;
        -  Protein: 1.2-1.5g/Kg&#xD;
&#xD;
        -  Lipid : 1-1.5g/Kg&#xD;
&#xD;
        -  Mineral and vitamins supply&#xD;
&#xD;
        -  Blood glucose control&#xD;
&#xD;
        -  Daily monitoring by dietician and specialized nurse&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">April 5, 2017</completion_date>
  <primary_completion_date type="Actual">November 27, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative complication</measure>
    <time_frame>at discharge. (expected the duration of hospital stay of postoperation is 4~6 weeks.)</time_frame>
    <description>expected the duration of hospital stay of postoperation is 4~6 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative hospital stay</measure>
    <time_frame>expected the duration of hospital stay of postoperation is 4~6 weeks.</time_frame>
    <description>expected the duration of hospital stay of postoperation is 4~6 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>preoperative, postoperative 14days</time_frame>
    <description>preoperative, postoperative 14days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative cost( + nutritional support cost)</measure>
    <time_frame>at discharge. (expected the duration of hospital stay of postoperation is 4~6 weeks.)</time_frame>
    <description>expected the duration of hospital stay of postoperation is 4~6 weeks.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>immunologic change(CD4/CD8) after nutritional support</measure>
    <time_frame>preoperative, postoperative 14days</time_frame>
    <description>CD4/CD8, immunoglobulin G, M, A</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Pancreatic Cancer</condition>
  <condition>Biliary Cancer</condition>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>nutritional support program apply</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preoperative nutritional support program is given for 5 or more days preoperatively by nutritional support program.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>historical control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Historical control group is that did not receiving</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>nutritional support program</intervention_name>
    <description>Nutritional support program is briefly described below.&#xD;
Interval: 5-10 days Contents: admission is required&#xD;
Calories: 30-35Kg, via enteral or parenteral&#xD;
Protein: 1.2-1.5g/Kg&#xD;
Lipid : 1-1.5g/Kg&#xD;
Mineral and vitamins supply&#xD;
Blood glucose control&#xD;
Daily monitoring by dietician and specialized nurse</description>
    <arm_group_label>nutritional support program apply</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subjects in anticipating major surgery of hepatobiliary pancreatic cancer&#xD;
&#xD;
          2. Patients diagnosed with malnutrition (at least more than one)&#xD;
&#xD;
               1. PG-SGA B or C&#xD;
&#xD;
               2. Weight loss &gt;10% within 6 month&#xD;
&#xD;
               3. BMI &lt;18.5&#xD;
&#xD;
               4. Serum Albumin &lt;3.0&#xD;
&#xD;
          3. Age less than 80 years old over 20 years old&#xD;
&#xD;
          4. Performance status (ECOG scale): 0-1&#xD;
&#xD;
          5. Adequate organ functions&#xD;
&#xD;
               1. Hb ≥7.0 g/dl&#xD;
&#xD;
               2. ANC ≥1,500/mm3&#xD;
&#xD;
               3. PLT ≥80,000/mm3&#xD;
&#xD;
               4. Liver function: AST/ALT ≤5×upper limit of normal&#xD;
&#xD;
               5. Creatinine ≤2.0 ULN&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Biopsy, drainage tube insertion, and other minor surgery&#xD;
&#xD;
          2. palliative surgery&#xD;
&#xD;
          3. Serious illness or medical conditions, as follows;&#xD;
&#xD;
               1. congestive heart failure (NYHA class III or IV)&#xD;
&#xD;
               2. unstable angina or myocardial infarction within the past 6 months,&#xD;
&#xD;
               3. significant arrhythmias requiring medication and conduction abnormality such as&#xD;
                  over 2nd degree AV block&#xD;
&#xD;
               4. uncontrolled hypertension&#xD;
&#xD;
               5. hepatic cirrhosis( ≥ Child class B)&#xD;
&#xD;
               6. interstitial pneumonia, pulmonary adenomatosis&#xD;
&#xD;
               7. psychiatric disorder that may interfere with and/or protocol compliance&#xD;
&#xD;
               8. unstable diabetes mellitus&#xD;
&#xD;
               9. uncontrolled ascites or pleural effusion&#xD;
&#xD;
              10. active infection&#xD;
&#xD;
          4. Pregnancy&#xD;
&#xD;
          5. Any patients judged by the investigator to be unfit to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SangJae Park</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center, Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>410-769</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 8, 2015</study_first_submitted>
  <study_first_submitted_qc>December 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2015</study_first_posted>
  <last_update_submitted>June 7, 2018</last_update_submitted>
  <last_update_submitted_qc>June 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Sang-Jae Park</investigator_full_name>
    <investigator_title>Head of Center for Liver Cancer, Chief of the Liver and Pancreatobiliary Cancer Branch</investigator_title>
  </responsible_party>
  <keyword>malnutrition</keyword>
  <keyword>nutrition</keyword>
  <keyword>nutritional support</keyword>
  <keyword>hepatobiliary pancreatic cancer</keyword>
  <keyword>hepatobiliary pancreatic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

